{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T12:58:40Z","timestamp":1765976320700,"version":"3.40.3"},"publisher-location":"Cham","reference-count":167,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030573775"},{"type":"electronic","value":"9783030573782"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/164_2019_329","type":"book-chapter","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T09:02:58Z","timestamp":1575882178000},"page":"451-473","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["New Targets and Emergent Therapies for Osteoporosis"],"prefix":"10.1007","author":[{"given":"Robert","family":"Brommage","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,10]]},"reference":[{"key":"329_CR1","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.bone.2011.02.008","volume":"48","author":"F Agholme","year":"2011","unstructured":"Agholme F, Isaksson H, Kuhstoss S, Aspenberg P (2011) The effects of Dickkopf-1 antibody on metaphyseal bone and implant fixation under different loading conditions. Bone 48:988\u2013996","journal-title":"Bone"},{"key":"329_CR2","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1016\/j.bmcl.2009.07.084","volume":"19","author":"JG Allen","year":"2009","unstructured":"Allen JG, Lee MR, Han CY, Scherrer J, Flynn S, Boucher C, Zhao H, O\u2019Connor AB, Roveto P, Bauer D et al (2009) Identification of small molecule inhibitors of proline-rich tyrosine kinase 2 (Pyk2) with osteogenic activity in osteoblast cells. Bioorg Med Chem Lett 19:4924\u20134928","journal-title":"Bioorg Med Chem Lett"},{"key":"329_CR3","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1021\/jm9018756","volume":"53","author":"JG Allen","year":"2010","unstructured":"Allen JG, Fotsch C, Babij P (2010) Emerging targets in osteoporosis disease modification. J Med Chem 53:4332\u20134353","journal-title":"J Med Chem"},{"key":"329_CR4","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/jbmr.1768","volume":"27","author":"EB Andrews","year":"2012","unstructured":"Andrews EB, Gilsean AW, Midkiff K, Sherrill B, Wu Y, Mann BH, Masica D (2012) The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years. J Bone Miner Res 27:2429\u20132437","journal-title":"J Bone Miner Res"},{"key":"329_CR5","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S2213-8587(18)30292-4","volume":"6","author":"Anonymous","year":"2018","unstructured":"Anonymous (2018) Osteoporosis: a roadmap to close the treatment gap. Lancet Diabetes Endocrinol 6:833","journal-title":"Lancet Diabetes Endocrinol"},{"key":"329_CR6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jbmr.3291","volume":"33","author":"N Ansari","year":"2018","unstructured":"Ansari N, Ho PW, Crimeen-Irwin B, Poulton IJ, Brunt AR, Forwood MR, Divieti Pajevic P, Gooi JH, Martin TJ, Sims NA (2018) Autocrine and paracrine regulation of the murine skeleton by osteocyte-derived parathyroid hormone-related protein. J Bone Miner Res 33:137\u2013153","journal-title":"J Bone Miner Res"},{"key":"329_CR7","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s11914-019-00517-x","volume":"17","author":"U Ayturk","year":"2019","unstructured":"Ayturk U (2019) RNA-seq in skeletal biology. Curr Osteoporos Rep 17:178\u2013185","journal-title":"Curr Osteoporos Rep"},{"key":"329_CR8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fendo.2019.00006","volume":"10","author":"DJM Bergen","year":"2019","unstructured":"Bergen DJM, Kague E, Hammond CL (2019) Zebrafish as an emerging model for osteoporosis: a primary testing platform for screening new osteo-active compounds. Front Endocrinol (Lausanne) 10:6","journal-title":"Front Endocrinol (Lausanne)"},{"key":"329_CR9","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.bone.2009.02.013","volume":"44","author":"PV Bodine","year":"2009","unstructured":"Bodine PV, Stauffer B, Ponce-de-Leon H, Bhat RA, Mangine A, Seestaller-Wehr LM, Moran RA, Billiard J, Fukayama S, Komm BS et al (2009) A small molecule inhibitor of the Wnt antagonist secreted frizzled-related protein-1 stimulates bone formation. Bone 44:1063\u20131068","journal-title":"Bone"},{"key":"329_CR10","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1359\/jbmr.2002.17.7.1139","volume":"17","author":"B Borah","year":"2002","unstructured":"Borah B, Dufresne TE, Chmielewski PA, Gross GJ, Prenger MC, Phipps RJ (2002) Risedronate preserves trabecular architecture and increases bone strength in vertebra of ovariectomized minipigs as measured by three-dimensional microcomputed tomography. J Bone Miner Res 17:1139\u20134117","journal-title":"J Bone Miner Res"},{"key":"329_CR11","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/jbmr.3160","volume":"32","author":"E Boudin","year":"2017","unstructured":"Boudin E, Yorgan T, Fijalkowski I, Sonntag S, Steenackers E, Hendrickx G, Peeters S, De Mar\u00e9 A, Vervaet B, Verhulst A et al (2017) The Lrp4R1170Q homozygous knock-in mouse recapitulates the bone phenotype of sclerosteosis in humans. J Bone Miner Res 32:1739\u20131749","journal-title":"J Bone Miner Res"},{"key":"329_CR12","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/jbmr.5650110508","volume":"11","author":"RW Boyce","year":"1996","unstructured":"Boyce RW, Paddock CL, Franks AF, Jankowsky ML, Eriksen EF (1996) Effects of intermittent hPTH(1-34) alone and in combination with 1,25(OH)(2)D(3) or risedronate on endosteal bone remodeling in canine cancellous and cortical bone. J Bone Miner Res 11:600\u2013613","journal-title":"J Bone Miner Res"},{"key":"329_CR13","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1056\/NEJMoa013444","volume":"346","author":"LM Boyden","year":"2002","unstructured":"Boyden LM, Mao J, Belsky J, Mitzner L, Farhi A, Mitnick MA, Wu D, Insogna K, Lifton RP (2002) High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 346:1513\u20131521","journal-title":"N Engl J Med"},{"key":"329_CR14","first-page":"307","volume":"1","author":"R Brommage","year":"2001","unstructured":"Brommage R (2001) Perspectives on using nonhuman primates to understand the etiology and treatment of postmenopausal osteoporosis. J Musculoskelet Neuronal Interact 1:307\u2013325","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"329_CR16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.beem.2018.02.006","volume":"32","author":"R Brommage","year":"2018","unstructured":"Brommage R, Ohlsson C (2018) Translational studies provide insights for the etiology and treatment of cortical bone osteoporosis. Best Pract Res Clin Endocrinol Metab 32:329\u2013340","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"329_CR18","doi-asserted-by":"crossref","first-page":"14034","DOI":"10.1038\/boneres.2014.34","volume":"2","author":"R Brommage","year":"2014","unstructured":"Brommage R, Liu J, Hansen GM, Kirkpatrick LL, Potter DG, Sands AT, Zambrowicz B, Powell DR, Vogel P (2014) High-throughput screening of mouse gene knockouts identifies established and novel skeletal phenotypes. Bone Res 2:14034","journal-title":"Bone Res"},{"key":"329_CR19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41413-018-0038-3","volume":"7","author":"R Brommage","year":"2019","unstructured":"Brommage R, Liu J, Vogel P, Mseeh F, Thompson AY, Potter DG, Shadoan MK, Hansen GM, Jeter-Jones S, Cui J et al (2019) NOTUM inhibition increases endocortical bone formation and bone strength. Bone Res 7:2","journal-title":"Bone Res"},{"issue":"Suppl 1","key":"329_CR20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/ocr.12282","volume":"22","author":"WA Bullock","year":"2019","unstructured":"Bullock WA, Pavalko FM, Robling AG (2019) Osteocytes and mechanical loading: the Wnt connection. Orthod Craniofac Res 22(Suppl 1):175\u2013179","journal-title":"Orthod Craniofac Res"},{"key":"329_CR21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00335-019-09804-5","volume":"30","author":"P Cacheiro","year":"2019","unstructured":"Cacheiro P, Haendel MA, Smedley D, International Mouse Phenotyping Consortium and the Monarch Initiative (2019) New models for human disease from the International Mouse Phenotyping Consortium. Mamm Genome 30:143\u2013150","journal-title":"Mamm Genome"},{"key":"329_CR22","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.1038\/mtna.2015.21","volume":"4","author":"M Capulli","year":"2015","unstructured":"Capulli M, Maurizi A, Ventura L, Rucci N, Teti A (2015) Effective small interfering RNA therapy to treat CLCN7-dependent autosomal dominant osteopetrosis type 2. Mol Ther Nucleic Acids 4:e248","journal-title":"Mol Ther Nucleic Acids"},{"key":"329_CR23","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","volume":"290","author":"JA Cauley","year":"2003","unstructured":"Cauley JA, Robbins J, Chen Z, Cummings SR, Jackson RD, LaCroix AZ, LeBoff M, Lewis CE, McGowan J, Neuner J et al (2003) Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women\u2019s Health Initiative randomized trial. JAMA 290:1729\u20131738","journal-title":"JAMA"},{"key":"329_CR24","doi-asserted-by":"crossref","first-page":"E5187","DOI":"10.1073\/pnas.1413828111","volume":"111","author":"MK Chang","year":"2014","unstructured":"Chang MK, Kramer I, Huber T, Kinzel B, Guth-Gundel S, Leupin O, Kneissel M (2014) Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels. Proc Natl Acad Sci U S A 111:E5187\u2013E5195","journal-title":"Proc Natl Acad Sci U S A"},{"key":"329_CR25","doi-asserted-by":"crossref","first-page":"7810","DOI":"10.1096\/fj.201900201RR","volume":"33","author":"H Chen","year":"2019","unstructured":"Chen H, Ji X, Lee WC, Shi Y, Li B, Abel ED, Jiang D, Huang W, Long F (2019) Increased glycolysis mediates Wnt7b-induced bone formation. FASEB J 33:7810\u20137821","journal-title":"FASEB J"},{"key":"329_CR26","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41574-018-0118-x","volume":"15","author":"C Clemmensen","year":"2019","unstructured":"Clemmensen C, Finan B, M\u00fcller TD, DiMarchi RD, Tsch\u00f6p MH, Hofmann SM (2019) Emerging hormonal-based combination pharmacotherapies for the treatment of metabolic diseases. Nat Rev Endocrinol 15:90\u2013104","journal-title":"Nat Rev Endocrinol"},{"key":"329_CR27","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/jps.10346","volume":"92","author":"V Codrons","year":"2003","unstructured":"Codrons V, Vanderbist F, Verbeeck RK, Arras M, Lison D, Pr\u00e9at V, Vanbever R (2003) Systemic delivery of parathyroid hormone (1-34) using inhalation dry powders in rats. J Pharm Sci 92:938\u2013950","journal-title":"J Pharm Sci"},{"issue":"Pt A","key":"329_CR28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.addr.2015.10.005","volume":"99","author":"LE Cole","year":"2016","unstructured":"Cole LE, Vargo-Gogola T, Roeder RK (2016) Targeted delivery to bone and mineral deposits using bisphosphonate ligands. Adv Drug Deliv Rev 99(Pt A):12\u201327","journal-title":"Adv Drug Deliv Rev"},{"key":"329_CR29","doi-asserted-by":"crossref","first-page":"4829","DOI":"10.1021\/jm049874c","volume":"47","author":"PJ Coleman","year":"2004","unstructured":"Coleman PJ, Brashear KM, Askew BC, Hutchinson JH, McVean CA, Duong LT, Feuston BP, Fernandez-Metzler C, Gentile MA, Hartman GD et al (2004) Nonpeptide alphavbeta3 antagonists. Part 11: discovery and preclinical evaluation of potent alphavbeta3 antagonists for the prevention and treatment of osteoporosis. J Med Chem 47:4829\u20134837","journal-title":"J Med Chem"},{"key":"329_CR30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/jbm4.10020","volume":"2","author":"C Collet","year":"2017","unstructured":"Collet C, Ostertag A, Ricquebourg M, Delecourt M, Tueur G, Isidor B, Guillot P, Schaefer E, Javier RM, Funck-Brentano T et al (2017) Primary osteoporosis in young adults: genetic basis and identification of novel variants in causal genes. JBMR Plus 2:12\u201321","journal-title":"JBMR Plus"},{"key":"329_CR31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1210\/jc.2009-0358","volume":"95","author":"F Cosman","year":"2010","unstructured":"Cosman F, Lane NE, Bolognese MA, Zanchetta JR, Garcia-Hernandez PA, Sees K, Matriano JA, Gaumer K, Daddona PE (2010) Effect of transdermal teriparatide administration on bone mineral density in postmenopausal women. J Clin Endocrinol Metab 95:151\u2013158","journal-title":"J Clin Endocrinol Metab"},{"key":"329_CR32","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00198-015-3392-7","volume":"27","author":"F Cosman","year":"2016","unstructured":"Cosman F, Gilchrist N, McClung M, Foldes J, de Villiers T, Santora A, Leung A, Samanta S, Heyden N, McGinnis JP 2nd et al (2016) A phase 2 study of MK-5442, a calcium-sensing receptor antagonist, in postmenopausal women with osteoporosis after long-term use of oral bisphosphonates. Osteoporos Int 27:377\u2013386","journal-title":"Osteoporos Int"},{"key":"329_CR33","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cmet.2018.03.004","volume":"27","author":"ST Crooke","year":"2018","unstructured":"Crooke ST, Witztum JL, Bennett CF, Baker BF (2018) RNA-targeted therapeutics. Cell Metab 27:714\u2013739","journal-title":"Cell Metab"},{"key":"329_CR34","first-page":"16","volume":"95","author":"R Cross","year":"2017","unstructured":"Cross R (2017) The RNA drug hunters. Chem Eng News 95:16\u201318","journal-title":"Chem Eng News"},{"key":"329_CR35","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nm.2388","volume":"17","author":"Y Cui","year":"2011","unstructured":"Cui Y, Niziolek PJ, MacDonald BT, Zylstra CR, Alenina N, Robinson DR, Zhong Z, Matthes S, Jacobsen CM, Conlon RA et al (2011) Lrp5 functions in bone to regulate bone mass. Nat Med 17:684\u2013691","journal-title":"Nat Med"},{"key":"329_CR36","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0800743","volume":"359","author":"SR Cummings","year":"2008","unstructured":"Cummings SR, Ettinger B, Delmas PD, Kenemans P, Stathopoulos V, Verweij P, Mol-Arts M, Kloosterboer L, Mosca L, Christiansen C et al (2008) The effects of tibolone in older postmenopausal women. N Engl J Med 359:697\u2013708","journal-title":"N Engl J Med"},{"key":"329_CR37","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1056\/NEJMoa0808692","volume":"362","author":"SR Cummings","year":"2010","unstructured":"Cummings SR, Ensrud K, Delmas PD, LaCroix AZ, Vukicevic S, Reid DM, Goldstein S, Sriram U, Lee A, Thompson J et al (2010) Lasofoxifene in postmenopausal women with osteoporosis. N Engl J Med 362:686\u2013696","journal-title":"N Engl J Med"},{"key":"329_CR38","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/jbmr.3141","volume":"32","author":"J Delgado-Calle","year":"2017","unstructured":"Delgado-Calle J, Bellido T (2017) New insights into the local and systemic functions of sclerostin: regulation of quiescent bone lining cells and beige adipogenesis in peripheral fat depots. J Bone Miner Res 32:889\u2013891","journal-title":"J Bone Miner Res"},{"key":"329_CR39","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/jbmr.256","volume":"26","author":"HF DeLuca","year":"2011","unstructured":"DeLuca HF, Bedale W, Binkley N, Gallagher JC, Bolognese M, Peacock M, Aloia J, Clagett-Dame M, Plum L (2011) The vitamin D analogue 2MD increases bone turnover but not BMD in postmenopausal women with osteopenia: results of a 1-year phase 2 double-blind, placebo-controlled, randomized clinical trial. J Bone Miner Res 26:538\u2013545","journal-title":"J Bone Miner Res"},{"key":"329_CR40","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1210\/endo.136.8.7628403","volume":"136","author":"H Dobnig","year":"1995","unstructured":"Dobnig H, Turner RT (1995) Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 136:3632\u20133638","journal-title":"Endocrinology"},{"key":"329_CR41","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1101\/gad.13.18.2412","volume":"13","author":"WC Dougall","year":"1999","unstructured":"Dougall WC, Glaccum M, Charrier K, Rohrbach K, Brasel K, De Smedt T, Daro E, Smith J, Tometsko ME, Maliszewski CR et al (1999) RANK is essential for osteoclast and lymph node development. Genes Dev 13:2412\u20132424","journal-title":"Genes Dev"},{"key":"329_CR42","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1210\/er.2015-1114","volume":"38","author":"MT Drake","year":"2017","unstructured":"Drake MT, Clarke BL, Oursler MJ, Khosla S (2017) Cathepsin K inhibitors for osteoporosis: biology, potential clinical utility, and lessons learned. Endocr Rev 38:325\u2013350","journal-title":"Endocr Rev"},{"key":"329_CR43","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1083\/jcb.11.3.627","volume":"11","author":"HR Dudley","year":"1961","unstructured":"Dudley HR, Spiro D (1961) The fine structure of bone cells. J Biophys Biochem Cytol 11:627\u2013649","journal-title":"J Biophys Biochem Cytol"},{"key":"329_CR166","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.3653","volume":"34","author":"PR Ebeling","year":"2019","unstructured":"Ebeling PR, Akesson K, Bauer DC, Buchbinder R, Eastell R, Fink HA, Giangregorio L, Guanabens N, Kado D, Kallmes D et al (2019) The efficacy and safety of vertebral augmentation: a second ASBMR task force report. J Bone Miner Res 34:3\u201321","journal-title":"J Bone Miner Res"},{"key":"329_CR44","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fendo.2015.00082","volume":"6","author":"RG Erben","year":"2015","unstructured":"Erben RG (2015) Hypothesis: coupling between resorption and formation in cancellous bone remodeling is a mechanically controlled event. Front Endocrinol (Lausanne) 6:82","journal-title":"Front Endocrinol (Lausanne)"},{"key":"329_CR45","doi-asserted-by":"crossref","first-page":"16032","DOI":"10.1038\/boneres.2016.32","volume":"4","author":"L Fan","year":"2016","unstructured":"Fan L, Pei S, Lucas Lu X, Wang L (2016) A multiscale 3D finite element analysis of fluid\/solute transport in mechanically loaded bone. Bone Res 4:16032","journal-title":"Bone Res"},{"key":"329_CR46","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/nm.4385","volume":"23","author":"JN Farr","year":"2017","unstructured":"Farr JN, Xu M, Weivoda MM, Monroe DG, Fraser DG, Onken JL, Negley BA, Sfeir JG, Ogrodnik MB et al (2017) Targeting cellular senescence prevents age-related bone loss in mice. Nat Med 23:1072\u20131079","journal-title":"Nat Med"},{"key":"329_CR47","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1210\/jc.2010-2855","volume":"96","author":"LA Fitzpatrick","year":"2011","unstructured":"Fitzpatrick LA, Dabrowski CE, Cicconetti G, Gordon DN, Papapoulos S, Bone HG 3rd, Bilezikian JP (2011) The effects of ronacaleret, a calcium-sensing receptor antagonist, on bone mineral density and biochemical markers of bone turnover in postmenopausal women with low bone mineral density. J Clin Endocrinol Metab 96:2441\u20132449","journal-title":"J Clin Endocrinol Metab"},{"key":"329_CR48","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1177\/1087057105279952","volume":"10","author":"A Fleming","year":"2005","unstructured":"Fleming A, Sato M, Goldsmith P (2005) High-throughput in vivo screening for bone anabolic compounds with zebrafish. J Biomol Screen 10:823\u2013831","journal-title":"J Biomol Screen"},{"key":"329_CR49","doi-asserted-by":"crossref","first-page":"11505","DOI":"10.1038\/ncomms11505","volume":"7","author":"M Florio","year":"2016","unstructured":"Florio M, Gunasekaran K, Stolina M, Li X, Liu L, Tipton B, Salimi-Moosavi H, Asuncion FJ, Li C, Sun B et al (2016) A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair. Nat Commun 7:11505","journal-title":"Nat Commun"},{"key":"329_CR50","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0169-6009(92)90809-R","volume":"18","author":"HM Frost","year":"1992","unstructured":"Frost HM, Jee WS (1992) On the rat model of human osteopenias and osteoporoses. Bone Miner 18:227\u2013236","journal-title":"Bone Miner"},{"key":"329_CR51","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/jbmr.1627","volume":"27","author":"RI Gafni","year":"2012","unstructured":"Gafni RI, Brahim JS, Andreopoulou P, Bhattacharyya N, Kelly MH, Brillante BA, Reynolds JC, Hua Z, Dempster DW, Collins MT (2012) Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure. J Bone Miner Res 27:1811\u20131820","journal-title":"J Bone Miner Res"},{"key":"329_CR52","doi-asserted-by":"crossref","first-page":"e0211076","DOI":"10.1371\/journal.pone.0211076","volume":"14","author":"JD Gardinier","year":"2019","unstructured":"Gardinier JD, Daly-Seiler C, Rostami N, Kundal S, Zhang C (2019) Loss of the PTH\/PTHrP receptor along the osteoblast lineage limits the anabolic response to exercise. PLoS One 14:e0211076","journal-title":"PLoS One"},{"key":"329_CR53","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1007\/s00198-018-4604-8","volume":"29","author":"A Gilsenan","year":"2018","unstructured":"Gilsenan A, Harding A, Kellier-Steele N, Harris D, Midkiff K, Andrews E (2018) The Forteo Patient Registry linkage to multiple state cancer registries: study design and results from the first 8 years. Osteoporos Int 29:2335\u20132343","journal-title":"Osteoporos Int"},{"key":"329_CR54","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ajhg.2019.02.010","volume":"104","author":"GS Ginsburg","year":"2019","unstructured":"Ginsburg GS (2019) A global collaborative to advance genomic medicine. Am J Hum Genet 104:407\u2013409","journal-title":"Am J Hum Genet"},{"key":"329_CR55","doi-asserted-by":"crossref","first-page":"40135","DOI":"10.1074\/jbc.M110.166892","volume":"285","author":"H Glantschnig","year":"2010","unstructured":"Glantschnig H, Hampton RA, Lu P, Zhao JZ, Vitelli S, Huang L, Haytko P, Cusick T, Ireland C, Jarantow SW et al (2010) Generation and selection of novel fully human monoclonal antibodies that neutralize Dickkopf-1 (DKK1) inhibitory function in vitro and increase bone mass in vivo. J Biol Chem 285:40135\u201340147","journal-title":"J Biol Chem"},{"key":"329_CR56","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.bone.2006.10.019","volume":"40","author":"CC Gl\u00fcer","year":"2007","unstructured":"Gl\u00fcer CC, Scholz-Ahrens KE, Helfenstein A, Delling G, Timm W, A\u00e7il Y, Barkmann R, Hassenpflug J, Stampa B, Bauss F, Schrezenmeir J (2007) Ibandronate treatment reverses glucocorticoid-induced loss of bone mineral density and strength in minipigs. Bone 40:645\u2013655","journal-title":"Bone"},{"key":"329_CR57","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.bmcl.2016.12.053","volume":"27","author":"DR Goldberg","year":"2017","unstructured":"Goldberg DR, De Lombaert S, Aiello R, Bourassa P, Barucci N, Zhang Q, Paralkar V, Stein AJ, Holt M, Valentine J et al (2017) Optimization of spirocyclic proline tryptophan hydroxylase-1 inhibitors. Bioorg Med Chem Lett 27:413\u2013419","journal-title":"Bioorg Med Chem Lett"},{"key":"329_CR58","first-page":"746","volume":"18","author":"S Graham","year":"2009","unstructured":"Graham S, Gamie Z, Polyzois I, Narvani AA, Tzafetta K, Tsiridis E, Helioti M, Mantalaris A, Tsiridis E (2009) Prostaglandin EP2 and EP4 receptor agonists in bone formation and bone healing: in vivo and in vitro evidence. Expert Opin Investig Drugs 18:746\u2013766","journal-title":"Expert Opin Investig Drugs"},{"key":"329_CR59","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/jbmr.2706","volume":"31","author":"CL Gregson","year":"2016","unstructured":"Gregson CL, Wheeler L, Hardcastle SA, Appleton LH, Addison KA, Brugmans M, Clark GR, Ward KA, Paggiosi M, Stone M et al (2016) Mutations in known monogenic high bone mass loci only explain a small proportion of high bone mass cases. J Bone Miner Res 31:640\u2013649","journal-title":"J Bone Miner Res"},{"key":"329_CR60","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bone.2018.06.001","volume":"114","author":"CL Gregson","year":"2018","unstructured":"Gregson CL, Newell F, Leo PJ, Clark GR, Paternoster L, Marshall M, Forgetta V, Morris JA, Ge B, Bao X et al (2018) Genome-wide association study of extreme high bone mass: contribution of common genetic variation to extreme BMD phenotypes and potential novel BMD-associated genes. Bone 114:62\u201371","journal-title":"Bone"},{"key":"329_CR61","doi-asserted-by":"crossref","first-page":"E2207","DOI":"10.1210\/jc.2013-4009","volume":"99","author":"J Halse","year":"2014","unstructured":"Halse J, Greenspan S, Cosman F, Ellis G, Santora A, Leung A, Heyden N, Samanta S, Doleckyj S, Rosenberg E et al (2014) A phase 2, randomized, placebo-controlled, dose-ranging study of the calcium-sensing receptor antagonist MK-5442 in the treatment of postmenopausal women with osteoporosis. J Clin Endocrinol Metab 99:E2207\u2013E2215","journal-title":"J Clin Endocrinol Metab"},{"key":"329_CR62","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.bone.2012.01.009","volume":"50","author":"SP H\u00e4mmerle","year":"2012","unstructured":"H\u00e4mmerle SP, Mindeholm L, Launonen A, Kiese B, Loeffler R, Harfst E, Azria M, Arnold M, John MR (2012) The single dose pharmacokinetic profile of a novel oral human parathyroid hormone formulation in healthy postmenopausal women. Bone 50:965\u2013973","journal-title":"Bone"},{"key":"329_CR63","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.bmcl.2009.01.025","volume":"19","author":"CY Han","year":"2009","unstructured":"Han CY, Wang Y, Yu L, Powers D, Xiong X, Yu V, Nguyen Y, Jean DJ Jr, Babij P (2009) Small molecules with potent osteogenic-inducing activity in osteoblast cells. Bioorg Med Chem Lett 19:1442\u20131445","journal-title":"Bioorg Med Chem Lett"},{"key":"329_CR64","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s40610-017-0060-z","volume":"3","author":"H Hariri","year":"2017","unstructured":"Hariri H, Pellicelli M, Arnaud S (2017) New PTH signals mediating bone anabolism. Curr Mol Biol Rep 3:133\u2013141","journal-title":"Curr Mol Biol Rep"},{"key":"329_CR65","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.bone.2012.11.045","volume":"53","author":"K Henriksen","year":"2012","unstructured":"Henriksen K, Andersen JR, Riis BJ, Mehta N, Tavakkol R, Alexandersen P, Byrjalsen I, Valter I, Nedergaard BS, Teglbjaerg CS et al (2012) Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1-31)NH(2)] in postmenopausal women with osteoporosis. Bone 53:160\u2013166","journal-title":"Bone"},{"key":"329_CR66","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMra1706910","volume":"381","author":"KA High","year":"2019","unstructured":"High KA, Roncarolo MG (2019) Gene therapy. N Engl J Med 381:455\u2013464","journal-title":"N Engl J Med"},{"key":"329_CR67","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1359\/jbmr.1999.14.4.536","volume":"14","author":"T Hirano","year":"1999","unstructured":"Hirano T, Burr DB, Turner CH, Sato M, Cain RL, Hock JM (1999) Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits. J Bone Miner Res 14:536\u2013545","journal-title":"J Bone Miner Res"},{"key":"329_CR68","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1002\/jbmr.1978","volume":"28","author":"MJ Horwitz","year":"2013","unstructured":"Horwitz MJ, Augustine M, Khan L, Martin E, Oakley CC, Carneiro RM, Tedesco MB, Laslavic A, Sereika SM, Bisello A et al (2013) A comparison of parathyroid hormone-related protein (1-36) and parathyroid hormone (1-34) on markers of bone turnover and bone density in postmenopausal women: the PrOP study. J Bone Miner Res 28:2266\u20132276","journal-title":"J Bone Miner Res"},{"key":"329_CR69","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature12111","volume":"496","author":"K Howe","year":"2013","unstructured":"Howe K, Clark MD, Torroja CF, Torrance J, Berthelot C, Muffato M, Collins JE, Humphray S, McLaren K, Matthews L et al (2013) The zebrafish reference genome sequence and its relationship to the human genome. Nature 496:498\u2013503","journal-title":"Nature"},{"key":"329_CR70","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ame2.12000","volume":"1","author":"HX Huang","year":"2018","unstructured":"Huang HX, Lin H, Lan F, Wu YF, Yang ZG, Zhang JJ (2018) Application of bone transgenic zebrafish in anti-osteoporosis chemical screening. Animal Model Exp Med 1:53\u201361","journal-title":"Animal Model Exp Med"},{"key":"329_CR71","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4939-8997-3","volume-title":"Bone research protocols","author":"A Idris","year":"2019","unstructured":"Idris A (2019) Bone research protocols. Springer, New York"},{"key":"329_CR72","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S8756-3282(97)00147-6","volume":"21","author":"WS Jee","year":"1997","unstructured":"Jee WS, Ma YF (1997) The in vivo anabolic actions of prostaglandins in bone. Bone 21:297\u2013304","journal-title":"Bone"},{"key":"329_CR73","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S8756-3282(00)00430-0","volume":"28","author":"CP Jerome","year":"2001","unstructured":"Jerome CP, Burr DB, Van Bibber T, Hock JM, Brommage R (2001) Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis). Bone 28:150\u2013159","journal-title":"Bone"},{"key":"329_CR74","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.bone.2014.04.015","volume":"64","author":"MR John","year":"2014","unstructured":"John MR, Harfst E, Loeffler J, Belleli R, Mason J, Bruin GJ, Seuwen K, Klickstein LB, Mindeholm L, Widler L et al (2014) AXT914 a novel, orally-active parathyroid hormone-releasing drug in two early studies of healthy volunteers and postmenopausal women. Bone 64:204\u2013210","journal-title":"Bone"},{"key":"329_CR75","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1080\/01926230601072301","volume":"34","author":"J Jolette","year":"2006","unstructured":"Jolette J, Wilker CE, Smith SY, Doyle N, Hardisty JF, Metcalfe AJ, Marriott TB, Fox J, Wells DS (2006) Defining a noncarcinogenic dose of recombinant human parathyroid hormone 1-84 in a 2-year study in Fischer 344 rats. Toxicol Pathol 34:929\u2013940","journal-title":"Toxicol Pathol"},{"key":"329_CR167","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.yrtph.2017.04.001","volume":"86","author":"J Jolette","year":"2017","unstructured":"Jolette J, Attalla B, Varela A, Long GG, Mellal N, Trimm S, Smith SY, Ominsky MS, Hattersley G (2017) Comparing the incidence of bone tumors in rats chronically exposed to the selective PTH type 1 receptor agonist abaloparatide or PTH(1-34). Regul Toxicol Pharmacol 86:356\u2013365","journal-title":"Regul Toxicol Pharmacol"},{"key":"329_CR76","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.bone.2013.04.001","volume":"55","author":"RS Kao","year":"2013","unstructured":"Kao RS, Abbott MJ, Louie A, O\u2019Carroll D, Lu W, Nissenson R (2013) Constitutive protein kinase A activity in osteocytes and late osteoblasts produces an anabolic effect on bone. Bone 55:277\u2013287","journal-title":"Bone"},{"key":"329_CR77","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1002\/jbmr.1665","volume":"27","author":"SW Kim","year":"2012","unstructured":"Kim SW, Pajevic PD, Selig M, Barry KJ, Yang JY, Shin CS, Baek WY, Kim JE, Kronenberg HM (2012) Intermittent parathyroid hormone administration converts quiescent lining cells to active osteoblasts. J Bone Miner Res 27:2075\u20138204","journal-title":"J Bone Miner Res"},{"key":"329_CR78","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/jbmr.3038","volume":"32","author":"SW Kim","year":"2017","unstructured":"Kim SW, Lu Y, Williams EA, Lai F, Lee JY, Enishi T, Balani DH, Ominsky MS, Ke HZ, Kronenberg HM et al (2017) Sclerostin antibody administration converts bone lining cells into active osteoblasts. J Bone Miner Res 32:892\u2013901","journal-title":"J Bone Miner Res"},{"key":"329_CR79","doi-asserted-by":"crossref","first-page":"17642","DOI":"10.1038\/s41598-018-36097-6","volume":"8","author":"H Kim","year":"2018","unstructured":"Kim H, Kim YG, Choi W, Moon JH, Hwang I, Kim K, Yadav VK, Karsenty G, Jeong JS, Kim H (2018) Generation of a highly efficient and tissue-specific tryptophan hydroxylase 1 knockout mouse model. Sci Rep 8:17642","journal-title":"Sci Rep"},{"key":"329_CR80","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bone.2018.12.011","volume":"121","author":"PS Kishnani","year":"2019","unstructured":"Kishnani PS, Rockman-Greenberg C, Rauch F, Bhatti MT, Moseley S, Denker AE, Watsky E, Whyte MP (2019) Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia. Bone 121:149\u2013162","journal-title":"Bone"},{"key":"329_CR81","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S8756-3282(00)00448-8","volume":"28","author":"M Kneissel","year":"2001","unstructured":"Kneissel M, Boyde A, Gasser JA (2001) Bone tissue and its mineralization in aged estrogen-depleted rats after long-term intermittent treatment with parathyroid hormone (PTH) analog SDZ PTS 893 or human PTH(1-34). Bone 28:237\u2013250","journal-title":"Bone"},{"key":"329_CR82","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2147\/HP.S95960","volume":"3","author":"HJ Knowles","year":"2015","unstructured":"Knowles HJ (2015) Hypoxic regulation of osteoclast differentiation and bone resorption activity. Hypoxia (Auckl) 3:73\u201382","journal-title":"Hypoxia (Auckl)"},{"key":"329_CR83","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fendo.2019.00155","volume":"10","author":"LB Knudsen","year":"2019","unstructured":"Knudsen LB, Lau J (2019) The discovery and development of liraglutide and semaglutide. Front Endocrinol (Lausanne) 10:155","journal-title":"Front Endocrinol (Lausanne)"},{"key":"329_CR84","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/jbm4.10012","volume":"1","author":"FC Ko","year":"2017","unstructured":"Ko FC, Van Vliet M, Ellman R, Grasso D, Brooks DJ, Spatz JM, Conlon C, Aguirre JI, Wronski TJ, Bouxsein ML (2017) Treatment with a soluble bone morphogenetic protein type 1A receptor (BMPR1A) fusion protein increases bone mass and bone formation in mice subjected to hindlimb unloading. JBMR Plus 1:66\u201372","journal-title":"JBMR Plus"},{"key":"329_CR85","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1084\/jem.191.2.275","volume":"191","author":"K Kobayashi","year":"2000","unstructured":"Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N et al (2000) Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF\/RANKL-RANK interaction. J Exp Med 191:275\u2013286","journal-title":"J Exp Med"},{"unstructured":"Kolata G (2008) Bone finding may point to hope for osteoporosis. New York Times. https:\/\/www.nytimes.com\/2008\/11\/27\/health\/research\/27bone.html","key":"329_CR86"},{"key":"329_CR87","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1359\/jbmr.081112","volume":"24","author":"PJ Kostenuik","year":"2009","unstructured":"Kostenuik PJ, Nguyen HQ, McCabe J, Warmington KS, Kurahara C, Sun N, Chen C, Li L, Cattley RC, Van G et al (2009) Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine\/human) RANKL. J Bone Miner Res 24:182\u2013195","journal-title":"J Bone Miner Res"},{"key":"329_CR88","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bone.2019.02.009","volume":"126","author":"RY Kwon","year":"2019","unstructured":"Kwon RY, Watson CJ, Karasik D (2019) Using zebrafish to study skeletal genomics. Bone 126:37\u201350","journal-title":"Bone"},{"key":"329_CR89","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/1759720X16670154","volume":"8","author":"B Langdahl","year":"2016","unstructured":"Langdahl B, Ferrari S, Dempster DW (2016) Bone modeling and remodeling: potential as therapeutic targets for the treatment of osteoporosis. Ther Adv Musculoskelet Dis 8:225\u2013235","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"329_CR90","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/jbmr.3138","volume":"32","author":"MA Lawson","year":"2017","unstructured":"Lawson MA, Ebetino FH, Mazur A, Chantry AD, Paton-Hough J, Evans HR, Lath D, Tsoumpra MK, Lundy MW, Dobson RL et al (2017) The pharmacological profile of a novel highly potent bisphosphonate, OX14 (1-fluoro-2-(imidazo-[1,2-\u03b1]pyridin-3-yl)-ethyl-bisphosphonate). J Bone Miner Res 32:1860\u20131869","journal-title":"J Bone Miner Res"},{"key":"329_CR91","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1210\/er.2017-00064","volume":"38","author":"WC Lee","year":"2017","unstructured":"Lee WC, Guntur AR, Long F, Rosen CJ (2017) Energy metabolism of the osteoblast: implications for osteoporosis. Endocr Rev 38:255\u2013266","journal-title":"Endocr Rev"},{"key":"329_CR92","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2016.12.013","volume":"104","author":"EM Lewiecki","year":"2017","unstructured":"Lewiecki EM, Binkley N (2017) DXA: 30 years and counting: introduction to the 30th anniversary issue. Bone 104:1\u20133","journal-title":"Bone"},{"key":"329_CR93","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","volume":"97","author":"J Li","year":"2000","unstructured":"Li J, Sarosi I, Yan XQ, Morony S, Capparelli C, Tan HL, McCabe S, Elliott R, Scully S, Van G et al (2000) RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci U S A 97:1566\u20131571","journal-title":"Proc Natl Acad Sci U S A"},{"key":"329_CR94","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1002\/jbmr.472","volume":"26","author":"X Li","year":"2011","unstructured":"Li X, Grisanti M, Fan W, Asuncion FJ, Tan HL, Dwyer D, Han CY, Yu L, Lee J, Lee E et al (2011) Dickkopf-1 regulates bone formation in young growing rodents and upon traumatic injury. J Bone Miner Res 26:2610\u20132621","journal-title":"J Bone Miner Res"},{"key":"329_CR95","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/nyas.12750","volume":"1364","author":"C Li","year":"2016","unstructured":"Li C, Wang W, Xie L, Luo X, Cao X, Wan M (2016) Lipoprotein receptor\u2013related protein 6 is required for parathyroid hormone-induced Sost suppression. Ann N Y Acad Sci 1364:62\u201373","journal-title":"Ann N Y Acad Sci"},{"doi-asserted-by":"publisher","unstructured":"Lleras-Forero L, Winkler C, Schulte-Merker S (2019) Zebrafish and medaka as models for biomedical research of bone diseases. Dev Biol. https:\/\/doi.org\/10.1016\/j.ydbio.2019.07.009","key":"329_CR96","DOI":"10.1016\/j.ydbio.2019.07.009"},{"key":"329_CR97","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/joim.12369","volume":"277","author":"M Lorentzon","year":"2015","unstructured":"Lorentzon M, Cummings SR (2015) Osteoporosis: the evolution of a diagnosis. J Intern Med 277:650\u2013661","journal-title":"J Intern Med"},{"key":"329_CR98","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1152\/physrev.00028.2017","volume":"98","author":"JW Lowery","year":"2018","unstructured":"Lowery JW, Rosen V (2018) The BMP pathway and its inhibitors in the skeleton. Physiol Rev 98:2431\u20132452","journal-title":"Physiol Rev"},{"key":"329_CR99","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ymthe.2019.01.017","volume":"27","author":"JC Lui","year":"2019","unstructured":"Lui JC, Colbert M, Cheung CSF, Ad M, Lee A, Zhu Z, Barnes KM, Dimitrov DS, Baron J (2019) Cartilage-targeted IGF-1 treatment to promote longitudinal bone growth. Mol Ther 27:673\u2013680","journal-title":"Mol Ther"},{"key":"329_CR100","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fendo.2019.00070","volume":"10","author":"RE M\u00e4kitie","year":"2019","unstructured":"M\u00e4kitie RE, Costantini A, K\u00e4mpe A, Alm JJ, M\u00e4kitie O (2019) New insights into monogenic causes of osteoporosis. Front Endocrinol (Lausanne) 10:70","journal-title":"Front Endocrinol (Lausanne)"},{"key":"329_CR101","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1007\/s00198-011-1598-x","volume":"22","author":"R Marcus","year":"2011","unstructured":"Marcus R (2011) Present at the beginning: a personal reminiscence on the history of teriparatide. Osteoporos Int 22:2241\u20132248","journal-title":"Osteoporos Int"},{"key":"329_CR102","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1152\/physrev.00031.2015","volume":"96","author":"TJ Martin","year":"2016","unstructured":"Martin TJ (2016) Parathyroid hormone-related protein, its regulation of cartilage and bone development, and role in treating bone diseases. Physiol Rev 96:831\u2013871","journal-title":"Physiol Rev"},{"key":"329_CR103","doi-asserted-by":"crossref","first-page":"2930","DOI":"10.1002\/stem.2474","volume":"34","author":"I Matic","year":"2016","unstructured":"Matic I, Matthews BG, Wang X, Dyment NA, Worthley DL, Rowe DW, Grcevic D, Kalajzic I (2016) Quiescent bone lining cells are a major source of osteoblasts during adulthood. Stem Cells 34:2930\u20132942","journal-title":"Stem Cells"},{"key":"329_CR104","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3389\/fendo.2019.00277","volume":"10","author":"RD Maynard","year":"2019","unstructured":"Maynard RD, Ackert-Bicknell CL (2019) Mouse models and online resources for functional analysis of osteoporosis genome-wide association studies. Front Endocrinol (Lausanne) 10:277","journal-title":"Front Endocrinol (Lausanne)"},{"key":"329_CR168","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00223-017-0338-4","volume":"102","author":"MM McDonald","year":"2018","unstructured":"McDonald MM, Morse A, Schindeler A, Mikulec K, Peacock L, Cheng T, Bobyn J, Lee L, Baldock PA, Croucher PI et al (2018) Homozygous Dkk1 knockout mice exhibit high bone mass phenotype due to increased bone formation. Calcif Tissue Int 102:105\u2013116","journal-title":"Calcif Tissue Int"},{"key":"329_CR105","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1172\/JCI24918","volume":"115","author":"D Miao","year":"2005","unstructured":"Miao D, He B, Jiang Y, Kobayashi T, Soroc\u00e9anu MA, Zhao J, Su H, Tong X, Amizuka N, Gupta A et al (2005) Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34. J Clin Invest 115:2402\u20132411","journal-title":"J Clin Invest"},{"key":"329_CR106","doi-asserted-by":"crossref","first-page":"H1013","DOI":"10.1152\/ajpheart.00383.2017","volume":"313","author":"VM Miller","year":"2017","unstructured":"Miller VM, Harman SM (2017) An update on hormone therapy in postmenopausal women: mini-review for the basic scientist. Am J Physiol Heart Circ Physiol 313:H1013\u2013H1021","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"329_CR107","first-page":"953","volume":"3","author":"SC Miller","year":"1989","unstructured":"Miller SC, de Saint-Georges L, Bowman BM, Jee WS (1989) Bone lining cells: structure and function. Scanning Microsc 3:953\u2013960","journal-title":"Scanning Microsc"},{"key":"329_CR108","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.bone.2008.01.029","volume":"42","author":"MA Miller","year":"2008","unstructured":"Miller MA, Bare SP, Recker RR, Smith SY, Fox J (2008) Intratrabecular tunneling increases trabecular number throughout the skeleton of ovariectomized rhesus monkeys treated with parathyroid hormone 1-84. Bone 42:1175\u20131183","journal-title":"Bone"},{"key":"329_CR109","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3803\/EnM.2018.33.3.318","volume":"33","author":"MC Moorer","year":"2019","unstructured":"Moorer MC, Riddle RC (2019) Regulation of osteoblast metabolism by Wnt signaling. Endocrinol Metab (Seoul) 33:318\u2013330","journal-title":"Endocrinol Metab (Seoul)"},{"key":"329_CR110","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1517\/17425247.2.6.993","volume":"2","author":"P Morley","year":"2005","unstructured":"Morley P (2005) Delivery of parathyroid hormone for the treatment of osteoporosis. Expert Opin Drug Deliv 2:993\u20131002","journal-title":"Expert Opin Drug Deliv"},{"key":"329_CR111","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41588-018-0302-x","volume":"51","author":"JA Morris","year":"2019","unstructured":"Morris JA, Kemp JP, Youlten SE, Laurent L, Logan JG, Chai RC, Vulpescu NA, Forgetta V, Kleinman A, Mohanty S et al (2019) An atlas of genetic influences on osteoporosis in humans and mice. Nat Genet 51:258\u2013266","journal-title":"Nat Genet"},{"key":"329_CR112","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00223-018-0420-6","volume":"103","author":"A Morse","year":"2018","unstructured":"Morse A, Cheng TL, Schindeler A, McDonald MM, Mohanty ST, Kneissel M, Kramer I, Little DG (2018) Dkk1 KO mice treated with sclerostin antibody have additional increases in bone volume. Calcif Tissue Int 103:298\u2013310","journal-title":"Calcif Tissue Int"},{"doi-asserted-by":"publisher","unstructured":"Mortier GR, Cohn DH, Cormier-Daire V, Hall C, Krakow D, Mundlos S, Nishimura G, Robertson S, Sangiorgi L, Savarirayan R et al (2019) Nosology and classification of genetic skeletal disorders: 2019 revision. Am J Med Genet A. https:\/\/doi.org\/10.1002\/ajmg.a.61366","key":"329_CR169","DOI":"10.1002\/ajmg.a.61366"},{"key":"329_CR113","first-page":"237","volume":"18","author":"A Mullard","year":"2019","unstructured":"Mullard A (2019) First targeted protein degrader hits the clinic. Nat Rev Drug Discov 18:237\u2013239","journal-title":"Nat Rev Drug Discov"},{"key":"329_CR114","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1210\/jc.2004-2126","volume":"90","author":"MG Murphy","year":"2005","unstructured":"Murphy MG, Cerchio K, Stoch SA, Gottesdiener K, Wu M, Recker R, L-000845704 Study Group (2005) Effect of L-000845704, an alphaVbeta3 integrin antagonist, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women. J Clin Endocrinol Metab 90:2022\u20132028","journal-title":"J Clin Endocrinol Metab"},{"key":"329_CR115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41413-018-0036-5","volume":"7","author":"Y Nakai","year":"2019","unstructured":"Nakai Y, Okamoto K, Terashima A, Ehata S, Nishida J, Imamura T, Ono T, Takayanagi H (2019) Efficacy of an orally active small-molecule inhibitor of RANKL in bone metastasis. Bone Res 7:1","journal-title":"Bone Res"},{"key":"329_CR116","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/jbmr.2514","volume":"30","author":"PJ Niziolek","year":"2015","unstructured":"Niziolek PJ, MacDonald BT, Kedlaya R, Zhang M, Bellido T, He X, Warman ML, Robling AG (2015) High bone mass-causing mutant LRP5 receptors are resistant to endogenous inhibitors in vivo. J Bone Miner Res 30:1822\u20131830","journal-title":"J Bone Miner Res"},{"key":"329_CR117","doi-asserted-by":"crossref","first-page":"5224","DOI":"10.1210\/endo.139.12.6343","volume":"139","author":"ME Nuttall","year":"1998","unstructured":"Nuttall ME, Bradbeer JN, Stroup GB, Nadeau DP, Hoffman SJ, Zhao H, Rehm S, Gowen M (1998) Idoxifene: a novel selective estrogen receptor modulator prevents bone loss and lowers cholesterol levels in ovariectomized rats and decreases uterine weight in intact rats. Endocrinology 139:5224\u20135234","journal-title":"Endocrinology"},{"key":"329_CR118","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrd.2018.14","volume":"17","author":"TI Oprea","year":"2018","unstructured":"Oprea TI, Bologa CG, Brunak S, Campbell A, Gan GN, Gaulton A, Gomez SM, Guha R, Hersey A, Holmes J et al (2018) Unexplored therapeutic opportunities in the human genome. Nat Rev Drug Discov 17:317\u2013332","journal-title":"Nat Rev Drug Discov"},{"key":"329_CR119","doi-asserted-by":"crossref","first-page":"e88889","DOI":"10.1371\/journal.pone.0088889","volume":"9","author":"AK Pandey","year":"2014","unstructured":"Pandey AK, Lu L, Wang X, Homayouni R, Williams RW (2014) Functionally enigmatic genes: a case study of the brain ignorome. PLoS One 9:e88889","journal-title":"PLoS One"},{"key":"329_CR120","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","volume":"2","author":"AM Parfitt","year":"1987","unstructured":"Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR (1987) Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2:595\u2013610","journal-title":"J Bone Miner Res"},{"key":"329_CR121","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/jbmr.5650030610","volume":"3","author":"MJ Pead","year":"1988","unstructured":"Pead MJ, Skerry TM, Lanyon LE (1988) Direct transformation from quiescence to bone formation in the adult periosteum following a single brief period of bone loading. J Bone Miner Res 3:647\u2013656","journal-title":"J Bone Miner Res"},{"key":"329_CR122","doi-asserted-by":"crossref","first-page":"E265","DOI":"10.3390\/pharmaceutics11060265","volume":"11","author":"RG Pearson","year":"2019","unstructured":"Pearson RG, Masud T, Blackshaw E, Naylor A, Hinchcliffe M, Jeffery K, Jordan F, Shabir-Ahmed A, King G, Lewis AL et al (2019) Nasal administration and plasma pharmacokinetics of parathyroid hormone peptide PTH 1-34 for the treatment of osteoporosis. Pharmaceutics 11:E265","journal-title":"Pharmaceutics"},{"key":"329_CR123","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.bone.2008.08.130","volume":"44","author":"B Pennypacker","year":"2009","unstructured":"Pennypacker B, Shea M, Liu Q, Masarachia P, Saftig P, Rodan S, Rodan G, Kimmel D (2009) Bone density, strength, and formation in adult cathepsin K (\u2212\/\u2212) mice. Bone 44:199\u2013207","journal-title":"Bone"},{"key":"329_CR124","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/jbmr.223","volume":"26","author":"BL Pennypacker","year":"2011","unstructured":"Pennypacker BL, Duong LT, Cusick TE, Masarachia PJ, Gentile MA, Gauthier JY, Black WC, Scott BB, Samadfam R et al (2011) Cathepsin K inhibitors prevent bone loss in estrogen-deficient rabbits. J Bone Miner Res 26:252\u2013262","journal-title":"J Bone Miner Res"},{"key":"329_CR125","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1002\/jbmr.2211","volume":"29","author":"BL Pennypacker","year":"2014","unstructured":"Pennypacker BL, Chen CM, Zheng H, Shih MS, Belfast M, Samadfam R, Duong LT (2014) Inhibition of cathepsin K increases modeling-based bone formation, and improves cortical dimension and strength in adult ovariectomized monkeys. J Bone Miner Res 29:1847\u20131858","journal-title":"J Bone Miner Res"},{"doi-asserted-by":"publisher","unstructured":"Peplow M (2019) Click chemistry targets antibody-drug conjugates for the clinic. Nat Biotechnol. https:\/\/doi.org\/10.1038\/d41587-019-00017-4","key":"329_CR126","DOI":"10.1038\/d41587-019-00017-4"},{"key":"329_CR127","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1210\/endo-112-3-1000","volume":"112","author":"R Podbesek","year":"1983","unstructured":"Podbesek R, Edouard C, Meunier PJ, Parsons JA, Reeve J, Stevenson RW, Zanelli JM (1983) Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds. Endocrinology 112:1000\u20131006","journal-title":"Endocrinology"},{"key":"329_CR128","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/s42255-018-0005-8","volume":"1","author":"M Rauner","year":"2019","unstructured":"Rauner M, Baschant U, Roetto A, Pellegrino RM, Rother S, Salbach-Hirsch J, Weidner H, Hintze V, Campbell G, Petzold A et al (2019) Transferrin receptor 2 controls bone mass and pathological bone formation via BMP and Wnt signaling. Nat Metab 1:111\u2013124","journal-title":"Nat Metab"},{"key":"329_CR129","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/00016340500345691","volume":"85","author":"P Ravn","year":"2006","unstructured":"Ravn P, Nielsen TF, Christiansen C (2006) What can be learned from the levormeloxifene experience? Acta Obstet Gynecol Scand 85:135\u2013142","journal-title":"Acta Obstet Gynecol Scand"},{"key":"329_CR130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s001980170126","volume":"12","author":"JY Reginster","year":"2001","unstructured":"Reginster JY, Christiansen C, Roux C, Fechtenbaum J, Rouillon A, Tou KP (2001) Intermittent cyclic tiludronate in the treatment of osteoporosis. Osteoporos Int 12:169\u2013177","journal-title":"Osteoporos Int"},{"key":"329_CR131","doi-asserted-by":"crossref","first-page":"12690","DOI":"10.1002\/chem.201702117","volume":"23","author":"CA Rhodes","year":"2017","unstructured":"Rhodes CA, Pei D (2017) Bicyclic peptides as next-generation therapeutics. Chemistry 23:12690\u201312703","journal-title":"Chemistry"},{"key":"329_CR132","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1359\/JBMR.041114","volume":"20","author":"BL Riggs","year":"2005","unstructured":"Riggs BL, Parfitt AM (2005) Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling. J Bone Miner Res 20:177\u2013184","journal-title":"J Bone Miner Res"},{"key":"329_CR133","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1056\/NEJM199003223221203","volume":"322","author":"BL Riggs","year":"1990","unstructured":"Riggs BL, Hodgson SF, O\u2019Fallon WM, Chao EY, Wahner HW, Muhs JM, Cedel SL, Melton LJ 3rd (1990) Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 322:802\u2013809","journal-title":"N Engl J Med"},{"key":"329_CR134","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bone.2010.11.008","volume":"49","author":"MJ Rogers","year":"2011","unstructured":"Rogers MJ, Crockett JC, Coxon FP, M\u00f6nkk\u00f6nen J (2011) Biochemical and molecular mechanisms of action of bisphosphonates. Bone 49:34\u201341","journal-title":"Bone"},{"key":"329_CR135","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/jbmr.3543","volume":"33","author":"MR Rubin","year":"2018","unstructured":"Rubin MR, Zhou H, Cusano NE, Majeed R, Omeragic B, Gomez M, Nickolas TL, Dempster DW, Bilezikian JP (2018) The effects of long-term administration of rhPTH(1-84) in hypoparathyroidism by bone histomorphometry. J Bone Miner Res 33:1931\u20131939","journal-title":"J Bone Miner Res"},{"key":"329_CR136","doi-asserted-by":"crossref","first-page":"17054","DOI":"10.1074\/jbc.M109.099002","volume":"285","author":"A Schmidt","year":"2010","unstructured":"Schmidt A, Kimmel DB, Bai C, Scafonas A, Rutledge S, Vogel RL, McElwee-Witmer S, Chen F, Nantermet PV, Kasparcova V et al (2010) Discovery of the selective androgen receptor modulator MK-0773 using a rational development strategy based on differential transcriptional requirements for androgenic anabolism versus reproductive physiology. J Biol Chem 285:17054\u201317064","journal-title":"J Biol Chem"},{"key":"329_CR137","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/d41586-019-00879-3","volume":"567","author":"M Scudellari","year":"2019","unstructured":"Scudellari M (2019) Protein-slaying drugs could be the next blockbuster therapies. Nature 567:298\u2013300","journal-title":"Nature"},{"key":"329_CR138","doi-asserted-by":"crossref","first-page":"E749","DOI":"10.1152\/ajpendo.00343.2018","volume":"316","author":"Y Shao","year":"2019","unstructured":"Shao Y, Wichern E, Childress PJ, Adaway M, Misra J, Klunk A, Burr DB, Wek RC, Mosley AL, Liu Y et al (2019) Loss of Nmp4 optimizes osteogenic metabolism and secretion to enhance bone quality. Am J Physiol Endocrinol Metab 316:E749\u2013E772","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"329_CR139","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/ajp.20715","volume":"71","author":"SY Smith","year":"2009","unstructured":"Smith SY, Jolette J, Turner CH (2009) Skeletal health: primate model of postmenopausal osteoporosis. Am J Primatol 71:752\u2013765","journal-title":"Am J Primatol"},{"key":"329_CR140","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-56192-9","volume-title":"Bone toxicology","author":"SY Smith","year":"2017","unstructured":"Smith SY, Varela A, Samadfam R (2017) Bone toxicology. Springer, Cham"},{"key":"329_CR141","doi-asserted-by":"crossref","first-page":"e2006643","DOI":"10.1371\/journal.pbio.2006643","volume":"16","author":"T Stoeger","year":"2018","unstructured":"Stoeger T, Gerlach M, Morimoto RI, Nunes Amaral LA (2018) Large-scale investigation of the reasons why potentially important genes are ignored. PLoS Biol 16:e2006643","journal-title":"PLoS Biol"},{"key":"329_CR142","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1038\/s41467-019-09860-0","volume":"10","author":"U Styrkarsdottir","year":"2019","unstructured":"Styrkarsdottir U, Stefansson OA, Gunnarsdottir K, Thorleifsson G, Lund SH, Stefansdottir L, Juliusson K, Agustsdottir AB, Zink F, Halldorsson GH et al (2019) GWAS of bone size yields twelve loci that also affect height, BMD, osteoarthritis or fractures. Nat Commun 10:2054","journal-title":"Nat Commun"},{"key":"329_CR143","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1021\/acsnano.5b07828","volume":"10","author":"Y Sun","year":"2016","unstructured":"Sun Y, Ye X, Cai M, Liu X, Xiao J, Zhang C, Wang Y, Yang L, Liu J, Li S et al (2016) Osteoblast-targeting-peptide modified nanoparticle for siRNA\/microRNA delivery. ACS Nano 10:5759\u20135768","journal-title":"ACS Nano"},{"key":"329_CR144","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12951-019-0447-5","volume":"17","author":"X Sun","year":"2019","unstructured":"Sun X, Wei J, Lyu J, Bian T, Liu Z, Huang J, Pi F, Li C, Zhong Z (2019) Bone-targeting drug delivery system of biomineral-binding liposomes loaded with icariin enhances the treatment for osteoporosis. J Nanobiotechnol 17:10","journal-title":"J Nanobiotechnol"},{"key":"329_CR145","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1210\/en.2015-1614","volume":"157","author":"L Tascau","year":"2016","unstructured":"Tascau L, Gardner T, Anan H, Yongpravat C, Cardozo CP, Bauman WA, Lee FY, Oh DS, Tawfeek HA (2016) Activation of protein kinase A in mature osteoblasts promotes a major bone anabolic response. Endocrinology 157:112\u2013126","journal-title":"Endocrinology"},{"key":"329_CR146","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.bone.2015.12.013","volume":"84","author":"S Taylor","year":"2016","unstructured":"Taylor S, Ominsky MS, Hu R, Pacheco E, He YD, Brown DL, Aguirre JI, Wronski TJ, Buntich S, Afshari CA et al (2016) Time-dependent cellular and transcriptional changes in the osteoblast lineage associated with sclerostin antibody treatment in ovariectomized rats. Bone 84:148\u2013159","journal-title":"Bone"},{"key":"329_CR147","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2019.04.005","volume":"126","author":"K Trajanoska","year":"2019","unstructured":"Trajanoska K, Rivadeneira F (2019) The genetic architecture of osteoporosis and fracture risk. Bone 126:2\u201310","journal-title":"Bone"},{"key":"329_CR148","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/01926230252929882","volume":"30","author":"JL Vahle","year":"2002","unstructured":"Vahle JL, Sato M, Long GG, Young JK, Francis PC, Engelhardt JA, Westmore MS, Linda Y, Nold JB (2002) Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety. Toxicol Pathol 30:312\u2013321","journal-title":"Toxicol Pathol"},{"key":"329_CR149","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/01926230490462138","volume":"32","author":"JL Vahle","year":"2004","unstructured":"Vahle JL, Long GG, Sandusky G, Westmore M, Ma YL, Sato M (2004) Bone neoplasms in F344 rats given teriparatide [rhPTH(1-34)] are dependent on duration of treatment and dose. Toxicol Pathol 32:426\u2013348","journal-title":"Toxicol Pathol"},{"key":"329_CR150","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1359\/jbmr.080807","volume":"23","author":"JL Vahle","year":"2008","unstructured":"Vahle JL, Zuehlke U, Schmidt A, Westmore M, Chen P, Sato M (2008) Lack of bone neoplasms and persistence of bone efficacy in cynomolgus macaques after long-term treatment with teriparatide [rhPTH(1-34)]. J Bone Miner Res 23:2033\u20132039","journal-title":"J Bone Miner Res"},{"key":"329_CR151","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1126\/science.aaw1299","volume":"364","author":"JM van Deursen","year":"2019","unstructured":"van Deursen JM (2019) Senolytic therapies for healthy longevity. Science 364:636\u2013637","journal-title":"Science"},{"key":"329_CR152","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1002\/jbmr.5650111216","volume":"11","author":"BH Vickery","year":"1996","unstructured":"Vickery BH, Avnur Z, Cheng Y, Chiou SS, Leaffer D, Caulfield JP, Kimmel DB, Ho T, Krstenansky JL (1996) RS-66271, a C-terminally substituted analog of human parathyroid hormone-related protein (1-34), increases trabecular and cortical bone in ovariectomized, osteopenic rats. J Bone Miner Res 11:1943\u20131951","journal-title":"J Bone Miner Res"},{"key":"329_CR153","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1177\/0300985815626778","volume":"53","author":"P Vogel","year":"2016","unstructured":"Vogel P, Read RW, Hansen GM, Powell DR, Kantaputra PN, Zambrowicz B, Brommage R (2016) Dentin dysplasia in Notum knockout mice. Vet Pathol 53:853\u2013862","journal-title":"Vet Pathol"},{"key":"329_CR154","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1073\/pnas.1321605111","volume":"111","author":"SJ Warden","year":"2014","unstructured":"Warden SJ, Mantila Roosa SM, Kersh ME, Hurd AL, Fleisig GS, Pandy MG, Fuchs RK (2014) Physical activity when young provides lifelong benefits to cortical bone size and strength in men. Proc Natl Acad Sci U S A 111:5337\u20135342","journal-title":"Proc Natl Acad Sci U S A"},{"key":"329_CR155","doi-asserted-by":"crossref","first-page":"13176","DOI":"10.1038\/ncomms13176","volume":"7","author":"MN Wein","year":"2016","unstructured":"Wein MN, Liang Y, Goransson O, Sundberg TB, Wang J, Williams EA, O\u2019Meara MJ, Govea N, Beqo B, Nishimori S et al (2016) SIKs control osteocyte responses to parathyroid hormone. Nat Commun 7:13176","journal-title":"Nat Commun"},{"key":"329_CR156","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.cell.2008.09.059","volume":"135","author":"VK Yadav","year":"2008","unstructured":"Yadav VK, Ryu JH, Suda N, Tanaka KF, Gingrich JA, Sch\u00fctz G, Glorieux FH, Chiang CY, Zajac JD, Insogna KL et al (2008) Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 135:825\u2013837","journal-title":"Cell"},{"key":"329_CR157","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1038\/s41467-019-10809-6","volume":"10","author":"YS Yang","year":"2019","unstructured":"Yang YS, Xie J, Wang D, Kim JM, Tai PWL, Gravallese E, Gao G, Shim JH (2019) Bone-targeting AAV-mediated silencing of Schnurri-3 prevents bone loss in osteoporosis. Nat Commun 10:2958","journal-title":"Nat Commun"},{"key":"329_CR158","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S8756-3282(99)00220-3","volume":"25","author":"W Yao","year":"1999","unstructured":"Yao W, Jee WS, Zhou H, Lu J, Cui L, Setterberg R, Liang T, Ma Y (1999) Anabolic effect of prostaglandin E2 on cortical bone of aged male rats comes mainly from modeling-dependent bone gain. Bone 25:697\u2013702","journal-title":"Bone"},{"key":"329_CR159","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1073\/pnas.062053399","volume":"99","author":"K Yoshida","year":"2002","unstructured":"Yoshida K, Oida H, Kobayashi T, Maruyama T, Tanaka M, Katayama T, Yamaguchi K, Segi E, Tsuboyama T, Matsushita M et al (2002) Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Proc Natl Acad Sci U S A 99:4580\u20134585","journal-title":"Proc Natl Acad Sci U S A"},{"key":"329_CR160","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00198-017-4242-6","volume":"29","author":"MB Zanchetta","year":"2018","unstructured":"Zanchetta MB, Boailchuk J, Massari F, Silveira F, Bogado C, Zanchetta JR (2018) Significant bone loss after stopping long-term denosumab treatment: a post FREEDOM study. Osteoporos Int 29:41\u201347","journal-title":"Osteoporos Int"},{"key":"329_CR161","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S8756-3282(97)00198-1","volume":"21","author":"L Zhang","year":"1997","unstructured":"Zhang L, Takahashi HE, Inoue J, Tanizawa T, Endo N, Yamamoto N, Hori M (1997) Effects of intermittent administration of low dose human PTH(1-34) on cancellous and cortical bone of lumbar vertebral bodies in adult beagles. Bone 21:501\u2013506","journal-title":"Bone"},{"key":"329_CR162","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nm.2617","volume":"18","author":"G Zhang","year":"2012","unstructured":"Zhang G, Guo B, Wu H, Tang T, Zhang BT, Zheng L, He Y, Yang Z, Pan X, Chow H et al (2012) A delivery system targeting bone formation surfaces to facilitate RNAi-based anabolic therapy. Nat Med 18:307\u2013314","journal-title":"Nat Med"},{"key":"329_CR163","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1074\/jbc.M115.677807","volume":"291","author":"X Zhang","year":"2016","unstructured":"Zhang X, MacDonald BT, Gao H, Shamashkin M, Coyle AJ, Martinez RV, He X (2016) Characterization of Tiki, a new family of Wnt-specific metalloproteases. J Biol Chem 291:2435\u20132443","journal-title":"J Biol Chem"},{"key":"329_CR164","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.tibs.2018.09.002","volume":"43","author":"X Zhang","year":"2018","unstructured":"Zhang X, Dong S, Xu F (2018) Structural and druggability landscape of frizzled G protein-coupled receptors. Trends Biochem Sci 43:1033\u20131046","journal-title":"Trends Biochem Sci"},{"key":"329_CR165","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00223-013-9739-1","volume":"93","author":"Q Zhao","year":"2013","unstructured":"Zhao Q, Liu X, Zhang L, Shen X, Qi J, Wang J, Qian N, Deng L (2013) Bone selective protective effect of a novel bone-seeking estrogen on trabecular bone in ovariectomized rats. Calcif Tissue Int 93:172\u2013183","journal-title":"Calcif Tissue Int"}],"container-title":["Handbook of Experimental Pharmacology","Bone Regulators and Osteoporosis Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/164_2019_329","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T20:04:40Z","timestamp":1606593880000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/164_2019_329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030573775","9783030573782"],"references-count":167,"URL":"https:\/\/doi.org\/10.1007\/164_2019_329","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"type":"print","value":"0171-2004"},{"type":"electronic","value":"1865-0325"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"10 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}